DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,058 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,911,497 | +5.7% | 71,689 | +5.6% | 0.07% | +4.8% |
| Q1 2024 | $16,950,994 | +9.5% | 67,880 | +1.4% | 0.06% | -3.1% |
| Q4 2023 | $15,487,288 | -9.0% | 66,946 | -2.4% | 0.06% | -35.0% |
| Q3 2023 | $17,010,480 | +10.3% | 68,563 | +6.7% | 0.10% | +14.9% |
| Q2 2023 | $15,418,080 | +4.3% | 64,242 | +9.5% | 0.09% | -13.0% |
| Q1 2023 | $14,784,918 | -1.4% | 58,661 | +3.8% | 0.10% | -20.6% |
| Q4 2022 | $14,994,637 | +64.9% | 56,494 | +60.4% | 0.13% | +29.9% |
| Q3 2022 | $9,095,000 | +126.1% | 35,211 | +121.9% | 0.10% | +162.2% |
| Q2 2022 | $4,022,000 | -30.1% | 15,866 | -19.1% | 0.04% | +8.8% |
| Q1 2022 | $5,756,000 | -18.9% | 19,623 | -9.0% | 0.03% | -8.1% |
| Q4 2021 | $7,096,000 | +15.1% | 21,568 | +6.5% | 0.04% | -11.9% |
| Q3 2021 | $6,167,000 | +74.9% | 20,258 | +54.2% | 0.04% | +90.9% |
| Q2 2021 | $3,526,000 | +22.1% | 13,140 | +2.4% | 0.02% | +10.0% |
| Q1 2021 | $2,887,000 | +11.0% | 12,826 | +9.6% | 0.02% | -20.0% |
| Q4 2020 | $2,600,000 | -2.4% | 11,703 | -5.4% | 0.02% | -21.9% |
| Q3 2020 | $2,663,000 | -2.0% | 12,369 | -19.5% | 0.03% | -15.8% |
| Q2 2020 | $2,716,000 | +230.8% | 15,362 | +159.1% | 0.04% | +11.8% |
| Q1 2020 | $821,000 | -69.0% | 5,929 | -65.6% | 0.03% | -17.1% |
| Q4 2019 | $2,646,000 | +229.5% | 17,241 | +81.1% | 0.04% | +78.3% |
| Q2 2017 | $803,000 | – | 9,518 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |